- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Elisabeth Kohoutek
News 15 results
In the News · Source: Medtech Insight
Recognition
Recognition
June 22, 2023
King & Spalding Wins Impact Case of the Year Award
Recognition
April 12, 2023
Legal 500 EMEA 2023 Recognizes King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
February 17, 2023
Legal 500 Deutschland 2023 Recognizes King & Spalding Among Germany’s Leading Law Firms
In the News · Source: JUVE, Managing IP and Global Legal Chronicle
November 22, 2022
Ulf Grundmann and Elisabeth Kohoutek represent Novartis before the Court of Justice of the EU, which ruled in favor of the company in a pharma reboxing dispute
Cases & Deals
November 17, 2022
King & Spalding represents Novartis on landmark ECJ pharma packaging victory
Recognition
In the News · Source: JUVE
April 26, 2022
Wallaby Medical buys Phenox for 500 million euros
Recognition
April 12, 2022
Legal 500 EMEA 2022 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
January 28, 2022
Legal 500 Deutschland 2022 Ranks King & Spalding Among Germany’s Leading Law Firms
In the News · Source: Law360, Global Competition Review, Bloomberg Law, New York Law Journal, Law.com International, Global Arbitration Review, Daily Journal, The Deal, Intellectual Property Magazine, World Trademark Review, Commercial Dispute Resolution, Global Investigations Review, Le Monde du Droit, La Lettre des Juristes d’Affaires, Daily Report, The Oath, Houston Business Journal, The Texas Lawbook and Chicago Daily Bulletin
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities